Notice2024-19718
Notice of Closed Malaria Vaccine Development Program Scientific Advisory Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 4, 2024
Issuing agencies
Agency for International Development
Abstract
USAID is publishing this notice to announce a closed meeting of the USAID Malaria Vaccine Development Program (MVDP) Scientific Advisory Committee (SAC).
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 171 (Wednesday, September 4, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 171 (Wednesday, September 4, 2024)]
[Notices]
[Page 71878]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-19718]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 89, No. 171 / Wednesday, September 4, 2024 /
Notices
[[Page 71878]]
AGENCY FOR INTERNATIONAL DEVELOPMENT
Notice of Closed Malaria Vaccine Development Program Scientific
Advisory Committee Meeting
AGENCY: Agency for International Development (USAID).
ACTION: Notice of closed Federal advisory committee meeting.
-----------------------------------------------------------------------
SUMMARY: USAID is publishing this notice to announce a closed meeting
of the USAID Malaria Vaccine Development Program (MVDP) Scientific
Advisory Committee (SAC).
DATES: The meeting will be held Tuesday, October 22, 2024, from 8:00
a.m. to 5:30 p.m. Eastern Daylight Time (EDT) and Wednesday, October
23, 2024, from 8:00 a.m. to 3:00 p.m. EDT.
ADDRESSES: The closed meeting will be held at 455 Massachusetts Avenue
NW, Suite 1000, Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: Email: <a href="/cdn-cgi/l/email-protection#e8a5beacb8bba9abbb8d8b9a8d9c899a81899ca89d9b89818cc68f879e"><span class="__cf_email__" data-cfemail="c68b90829695878595a3a5b4a3b2a7b4afa7b286b3b5a7afa2e8a1a9b0">[email protected]</span></a>,
or Susan Youll, Designated Federal Officer, 202-712-4300 (Voice).
Mailing address is: USAID, 1300 Pennsylvania Ave NW, Washington, DC.
SUPPLEMENTARY INFORMATION:
Purpose of the Meeting: The MVDP SAC will consult with, provide
information to, and advise USAID on matters and issues relating to
malaria vaccine development, scientific technologies, and any other
related matters. The SAC will provide broad scientific review of USAID
MVDP activities and investments to ensure MVDP focus and coherence, and
to ensure the application of the highest standards of technical and
scientific excellence.
Background: The SAC consists of no more than 13 members with
demonstrated technical expertise and experience in areas related to
malaria vaccine development, including, but not limited to: vaccine
development, immunology, malariology, structural biology, preclinical
animal models, regulatory affairs, and clinical research. These
individuals may include, but not be limited to, employees of
international organizations involved in vaccine development, academic
institutions, pharmaceutical or biotechnology companies, and other U.S.
government agencies. The members will be selected to represent diverse
points of view and appointments will be made free from all forms of
discrimination. The members are appointed by the US Global Malaria
Coordinator.
As stated in its charter, the SAC's role is to:
(a) review written updates provided by the MVDP and their partners;
(b) receive presentations with data and progress from the last
meeting and any strategy changes from MVDP staff and partners,
(c) discuss data and ask questions of MVDP staff and partners
regarding presentations;
(d) submit a meeting report that may:
<bullet> provide strategic advice and scientific guidance;
<bullet> include recommendations on overall program strategy; and,
<bullet> identify new research and development opportunities that
support MVDP objectives.
MVDP SAC meetings are held approximately once a year. More
information USAID's Malaria Vaccine Development Program is available
at: <a href="https://www.usaid.gov/global-health/health-areas/malaria/research-innovation/malaria-vaccine-development-program-mvdp">https://www.usaid.gov/global-health/health-areas/malaria/research-innovation/malaria-vaccine-development-program-mvdp</a>.
Closed Meeting Exemption and Determination
This meeting is being held under the provisions of chapter 10 of
title 5, United States Code (U.S.C.) (commonly known as the ``Federal
Advisory Committee Act'' or ``FACA'') and 5 U.S.C. 552b (commonly known
as the ``Government in the Sunshine Act'').
The exemption is authorized by section 10(d) of the FACA, which
permits the closure of advisory committee meetings, or portions
thereof, if the head of the agency to which the advisory committee
reports determines such meetings may be closed to the public in
accordance with subsection (c) of the Government in the Sunshine Act (5
U.S.C. 552b(c)). In this case, the applicable provisions of 5 U.S.C.
552b(c) are subsection 552b(c)(4), which permits closure to protect
information that would disclose confidential trade secrets or
commercial property such as patentable material.
The Administrator, on April 9, 2024, delegated authority to close
MVDP SAC meetings to the public, to the U.S. Global Malaria
Coordinator. The Global Malaria Coordinator, with the concurrence of
the General Counsel, formally determined on August, 27, 2024, pursuant
to section 10 of the FACA, (5 U.S.C. 1009(d)), that the MVDP SAC
meeting shall be exempt from the provisions relating to public meetings
found in 5 U.S.C. 1009(a)(1) and 1009(a)(3).
Susan Youll,
USAID Designated Federal Officer for the MVDP SAC, Global Health
Bureau, U.S. Agency for International Development.
[FR Doc. 2024-19718 Filed 9-3-24; 8:45 am]
BILLING CODE 6116-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 4, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.